Interaction Guide · Research summary

Can I take Aluminum Hydroxide with Methylprednisolone?

Review Aluminum Hydroxide with Methylprednisolone: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

An absorption problem with methylprednisolone and aluminum hydroxide is not established by the available direct evidence. If the product is an antacid, ask the pharmacist to apply its specific timing advice.

What this answer covers

Oral methylprednisolone with aluminum hydroxide. Relevant studies used particular antacid mixtures and other corticosteroids; elemental nutrient entries are not identical to antacid formulations.

Supplement or preparation
Aluminum hydroxide
Medication ingredient
methylprednisolone

Which treatment this applies to

This review concerns oral methylprednisolone tablets such as MEDROL. A brief course and prolonged systemic therapy have different clinical contexts. It does not establish the same interactions for injections, depot esters or skin preparations.

What the studies actually tested

One small study found reduced prednisolone exposure after prednisone with aluminum/magnesium hydroxide mixtures. Other prednisone or prednisolone studies found no significant antacid effect. These are different corticosteroids and mixed antacid products, not direct methylprednisolone trials.

Distinguish an antacid from a nutrient

Tell the pharmacist the compound, formulation and reason for use. Aluminum hydroxide may be used for heartburn or prescribed phosphate control. Findings about a mixture cannot isolate the contribution of each ingredient or establish the same effect for every supplement.

Use the applicable product instructions

MedlinePlus names methylprednisolone in its aluminum hydroxide precautions and gives general advice to take other medicines one hour before or two hours after the antacid. This is precautionary guidance, not a trial proving the interval prevents this exact interaction. Confirm the schedule with your pharmacist and keep prescribed steroid treatment.

Evidence and practical considerations

Absorption & effectiveness

Other-corticosteroid antacid studies are conflicting and do not prove reduced methylprednisolone absorption with every aluminum hydroxide product.

Exact scope
Oral methylprednisolone with aluminum hydroxide. Relevant studies used particular antacid mixtures and other corticosteroids; elemental nutrient entries are not identical to antacid formulations. with Exact RxNorm 6902 IN methylprednisolone; MEDROL plain oral tablets. Injectable esters, depot formulations and topical products are not assumed equivalent.
Medication form and route
Oral

What remains uncertain

  • No direct exact-drug nutrient/antacid PK trial identified. Conflicting other-steroid studies and preparation-specific timing guidance cannot establish a universal absorption reduction.

Factors that may matter: Exact oral preparation and dose; Treatment duration and indication; Blood pressure and electrolyte status; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: Current prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed MEDROL methylprednisolone oral tablets.

Describes immune suppression, osteoporosis and calcium excretion; salt retention and potassium loss are less likely with synthetic derivatives except at large doses. Dietary adjustment or potassium supplementation may be necessary in context.

How this applies: Exact ingredient and specified formulation. Exact RxNorm 6902 IN methylprednisolone; MEDROL plain oral tablets. Injectable esters, depot formulations and topical products are not assumed equivalent.

Label does not prove universal deficiency or direct supplement absorption interactions. Dose, duration and formulation matter.

Source 2: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Five healthy volunteers and twelve patients with chronic active liver disease.

Measured prednisolone peaks and exposure were reduced with mixtures.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; prednisone/prednisolone is not methylprednisolone. Mixed salts do not isolate aluminum or magnesium effects, and liver disease changes applicability.

Source 3: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Human prednisone-antacid PK study.

No significant difference in peak, AUC or time to peak.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; different corticosteroid and formulations; no proof of exact-pair safety.

Source 4: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Nineteen healthy volunteers; six nonfasting participants had repeat antacid co-use.

Food altered absorption rate but not extent; antacid did not significantly change parameters in the nonfasting subgroup.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; small subgroup and different corticosteroid, not a validated methylprednisolone spacing experiment.

Source 5: Medication-use guidance

medlineplus.gov · Source check Sep 10, 2026

Population: People taking aluminum hydroxide medicines.

Names methylprednisolone among medicines to discuss and gives general advice to take other medicines one hour before or two hours after aluminum hydroxide.

How this applies: Exact drug named within a general antacid precaution.

Precautionary guidance, not an exact methylprednisolone exposure trial or proof that the interval was clinically validated for this pair.

Source 6: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

methylprednisolone is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Sources checked and article drafted.
Research summary published

Article revision: f9d8314009cea9cb

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.